Literature DB >> 17625141

Do high lipids help clearance of hepatitis C?

Stephen Ryder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17625141      PMCID： PMC1955489          DOI： 10.1136/gut.2006.108845

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  12 in total

1.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

Authors:  L Serfaty; T Andreani; P Giral; N Carbonell; O Chazouillères; R Poupon
Journal:  J Hepatol       Date:  2001-03       Impact factor: 25.083

3.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 4.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

5.  Low density lipoprotein receptor as a candidate receptor for hepatitis C virus.

Authors:  M Monazahian; I Böhme; S Bonk; A Koch; C Scholz; S Grethe; R Thomssen
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

6.  Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.

Authors:  Matthew A Wozniak; Ruth F Itzhaki; E Brian Faragher; Martin W James; Steven D Ryder; William L Irving
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

7.  Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

Authors:  P André; F Komurian-Pradel; S Deforges; M Perret; J L Berland; M Sodoyer; S Pol; C Bréchot; G Paranhos-Baccalà; V Lotteau
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?

Authors:  Pratima Sharma; Vijayan Balan; Jose Hernandez; Marianne Rosati; James Williams; Hector Rodriguez-Luna; Joan Schwartz; Edwyn Harrison; Monte Anderson; Thomas Byrne; Hugo E Vargas; David D Douglas; Jorge Rakela
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

9.  Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Authors:  Jean Michel Petit; Muriel Benichou; Laurence Duvillard; Valerie Jooste; Jean Baptiste Bour; Anne Minello; Bruno Verges; Jean Marcel Brun; Philippe Gambert; Patrick Hillon
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

10.  Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection.

Authors:  D A Price; M F Bassendine; S M Norris; C Golding; G L Toms; M L Schmid; C M Morris; A D Burt; P T Donaldson
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059
View more
  1 in total

Review 1.  Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy.

Authors:  Sylvia Drazilova; Jakub Gazda; Martin Janicko; Peter Jarcuska
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.